Matrix Metalloproteinase Proteolysis of the Myelin Basic Protein Isoforms Is a Source of Immunogenic Peptides in Autoimmune Multiple Sclerosis

Background Matrix metalloproteinases (MMPs) play a significant role in the fragmentation of myelin basic protein (MBP) and demyelination leading to autoimmune multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). The classic MBP isoforms are predominantly expressed in the oligodendrocytes of the CNS. The splice variants of the single MBP gene (Golli-MBP BG21 and J37) are widely expressed in the neurons and also in the immune cells. The relative contribution of the individual MMPs to the MBP cleavage is not known. Methodology/Principal Findings To elucidate which MMP plays the primary role in cleaving MBP, we determined the efficiency of MMP-2, MMP-8, MMP-9, MMP-10, MMP-12, MT1-MMP, MT2-MMP, MT3-MMP, MT4-MMP, MT5-MMP and MT6-MMP in the cleavage of the MBP, BG21 and J37 isoforms in the in vitro cleavage reactions followed by mass-spectroscopy analysis of the cleavage fragments. As a result, we identified the MMP cleavage sites and the sequence of the resulting fragments. We determined that MBP, BG21 and J37 are highly sensitive to redundant MMP proteolysis. MT6-MMP (initially called leukolysin), however, was superior over all of the other MMPs in cleaving the MBP isoforms. Using the mixed lymphocyte culture assay, we demonstrated that MT6-MMP proteolysis of the MBP isoforms readily generated, with a near quantitative yield, the immunogenic N-terminal 1–15 MBP peptide. This peptide selectively stimulated the proliferation of the PGPR7.5 T cell clone isolated from mice with EAE and specific for the 1–15 MBP fragment presented in the MHC H-2U context. Conclusions/Significance In sum, our biochemical observations led us to hypothesize that MT6-MMP, which is activated by furin and associated with the lipid rafts, plays an important role in MS pathology and that MT6-MMP is a novel and promising drug target in MS especially when compared with other individual MMPs.

[1]  L. Steinman,et al.  Antigen Specific Immunotherapy of Multiple Sclerosis , 2001, Journal of Clinical Immunology.

[2]  C. Campagnoni,et al.  Strain-related differences in the ability of T lymphocytes to recognize proteins encoded by the golli-myelin basic protein gene , 1996, Journal of Neuroimmunology.

[3]  A. Ferrando,et al.  Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. , 2000, Cancer research.

[4]  C. López-Otín,et al.  Collagenase-2 Deficiency or Inhibition Impairs Experimental Autoimmune Encephalomyelitis in Mice* , 2008, Journal of Biological Chemistry.

[5]  Lawrence Steinman,et al.  Multiple sclerosis: a two-stage disease , 2001, Nature Immunology.

[6]  H. Hartung,et al.  New concepts in the immunopathogenesis of multiple sclerosis , 2002, Nature Reviews Neuroscience.

[7]  C. Campagnoni,et al.  Human T lymphocytes specific for the immunodominant 83–99 epitope of myelin basic protein: Recognition of golli MBP HOG 7 , 1996, Journal of neuroscience research.

[8]  A. Waisman,et al.  Major T-cell responses in multiple sclerosis. , 1995, Molecular medicine today.

[9]  S. Shapiro,et al.  An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[11]  Helga E. de Vries,et al.  Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions , 2003, Journal of Neuroimmunology.

[12]  E. Sercarz,et al.  A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. , 2007, The Journal of clinical investigation.

[13]  N. Zečević,et al.  Expression of Golli proteins in adult human brain and multiple sclerosis lesions , 2002, Journal of Neuroimmunology.

[14]  Rosamund C Smith,et al.  MMP-28 as a regulator of myelination , 2008, BMC Neuroscience.

[15]  G J Barton,et al.  Application of multiple sequence alignment profiles to improve protein secondary structure prediction , 2000, Proteins.

[16]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[17]  C. Overall,et al.  Subcellular Distribution and Cytokine- and Chemokine-regulated Secretion of Leukolysin/MT6-MMP/MMP-25 in Neutrophils* , 2001, The Journal of Biological Chemistry.

[18]  C. Campagnoni,et al.  The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Y. Masuho,et al.  Membrane‐type 6 matrix metalloproteinase (MT6‐MMP, MMP‐25) is the second glycosyl‐phosphatidyl inositol (GPI)‐anchored MMP , 2000, FEBS letters.

[20]  H. D. de Vries,et al.  Matrix metalloproteinase‐19 is highly expressed in active multiple sclerosis lesions , 2006, Neuropathology and applied neurobiology.

[21]  D. Arnold,et al.  Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. , 2007, Archives of neurology.

[22]  M. Bernardo,et al.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer , 2008, Cancer and Metastasis Reviews.

[23]  W. Baumgärtner,et al.  MMP-12, MMP-3, and TIMP-1 Are Markedly Upregulated in Chronic Demyelinating Theiler Murine Encephalomyelitis , 2006, Journal of neuropathology and experimental neurology.

[24]  T. Owens,et al.  Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system , 2007, Journal of Neuroinflammation.

[25]  C. G. Knight [6] Active-site titration of peptidases , 1995 .

[26]  E. Bongarzone,et al.  New insights on the biology of myelin basic protein gene: The neural‐Immune connection , 2000, Journal of neuroscience research.

[27]  J. S. Sodhi,et al.  Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. , 2004, Journal of molecular biology.

[28]  M. Moscarello,et al.  Differences in Susceptibility of MBP Charge Isomers to Digestion by Stromelysin-1 (MMP-3) and Release of an Immunodominant Epitope , 2006, Neurochemical Research.

[29]  C. Weber,et al.  MMP25 (MT6-MMP) Is Highly Expressed in Human Colon Cancer, Promotes Tumor Growth, and Exhibits Unique Biochemical Properties* , 2007, Journal of Biological Chemistry.

[30]  Ji-Ming Feng Minireview: Expression and Function of Golli Protein in Immune System , 2007, Neurochemical Research.

[31]  H. Mcdevitt,et al.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.

[32]  H. McFarland,et al.  Epitope spreading occurs in active but not passive EAE induced by myelin basic protein , 1996, Journal of Neuroimmunology.

[33]  V. Yong,et al.  Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro , 2008, Journal of Neuroimmunology.

[34]  C. Campagnoni,et al.  Embryonic Expression of the Myelin Basic Protein Gene: Identification of a Promoter Region That Targets Transgene Expression to Pioneer Neurons , 1998, The Journal of Neuroscience.

[35]  C. Campagnoni,et al.  Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. , 1993, The Journal of biological chemistry.

[36]  A. Strongin,et al.  Determination of matrix metalloproteinase activity using biotinylated gelatin. , 2000, Analytical biochemistry.

[37]  Theodore V. Tselios,et al.  Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice. , 2008, Journal of medicinal chemistry.

[38]  Vasso Apostolopoulos,et al.  Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators. , 2005, Journal of medicinal chemistry.

[39]  C. Colwell,et al.  Region-Specific Myelin Pathology in Mice Lacking the Golli Products of the Myelin Basic Protein Gene , 2005, The Journal of Neuroscience.

[40]  C. Campagnoni,et al.  The golli-myelin basic protein negatively regulates signal transduction in T lymphocytes , 2004, Journal of Neuroimmunology.

[41]  N. Zečević,et al.  Identification of Golli and myelin basic proteins in human brain during early development , 2002, Glia.

[42]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[43]  J. Strominger,et al.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. , 1997, The Journal of clinical investigation.

[44]  Theodore V. Tselios,et al.  Antagonistic effects of human cyclic MBP(87-99) altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferation. , 2002, Journal of medicinal chemistry.

[45]  M. D'hooghe,et al.  T‐cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls , 2001, Journal of neuroscience research.

[46]  D. Pei Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage , 1999, Cell Research.

[47]  G. Rosenberg Matrix Metalloproteinases and Neuroinflammation in Multiple Sclerosis , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[48]  C. G. Knight Active-site titration of peptidases. , 1995, Methods in enzymology.

[49]  R. Fridman,et al.  Identification and Role of the Homodimerization Interface of the Glycosylphosphatidylinositol-anchored Membrane Type 6 Matrix Metalloproteinase (MMP25)* , 2008, Journal of Biological Chemistry.

[50]  Robin J. M. Franklin,et al.  Why does remyelination fail in multiple sclerosis? , 2002, Nature Reviews Neuroscience.